Cargando…
Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
We measured immunoreactive EGF and TGF alpha in prostate tissue extracts obtained from 19 patients with benign prostatic hyperplasia (BPH) and 19 with cancer of the prostate (CaP). Whilst both BPH and CaP expressed EGF (BPH = 195.61 +/- 19.94 ng g-1 protein; CaP = 235.60 +/- 24.45 ng g-1 protein) an...
Autores principales: | Yang, Y., Chisholm, G. D., Habib, F. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968204/ https://www.ncbi.nlm.nih.gov/pubmed/7678977 |
Ejemplares similares
-
Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor.
por: Mellon, J. K., et al.
Publicado: (1996) -
Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha
Publicado: (1985) -
Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995) -
Epidermal and transforming growth factor alpha in patients with breast tumours.
por: Gregory, H., et al.
Publicado: (1989) -
Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
por: Sherwood, E. R., et al.
Publicado: (1998)